HOW TO MINIMIZE THE BLEEDING RISK IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS: LESSONS DRAWN FROM RANDOMIZED TRIALS AND NEW CLINICAL GUIDELINES
In the current practice, patients with atrial fibrillation receive triple antithrombotic therapy after PCI, which includes aspirin, clopidogrel and oral anticoagulant. Several clinical trials were conducted to identify an alternative strategy for antithrombotic therapy that would minimize the risk o...
Saved in:
Main Authors: | O. O. Shakhmatova (Author), Е. P. Panchenko (Author) |
---|---|
Format: | Book |
Published: |
«REMEDIUM GROUP» Ltd.,
2018-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antithrombotic therapy in patients with atrial fibrillation and percutaneous coronary intervention: what has changed in the guidelines in 2020?
by: E. P. Panchenko
Published: (2020) -
STRATEGY TO MINIMIZE THE BLEEDING RISKS IN PATIENTS WITH ATRIAL FIBRILLATION WHO RECEIVE COMBINED ANTITHROMBOTIC THERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION
by: D. A. Zateishchikov
Published: (2018) -
Antithrombotic Management for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
by: A. V. Panov
Published: (2021) -
APIXABAN IN THE TREATMENT OF ATRIAL FIBRILLATION: RANDOMIZED TRIALS AND EVERYDAY CLINICAL PRACTICE
by: O. O. Shakhmatova, et al.
Published: (2017) -
Critical Appraisal of Guidelines for Antithrombotic Therapy in Atrial Fibrillation Post-Percutaneous Coronary Intervention
by: Yongqiang Fan, et al.
Published: (2022)